X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23) 23
cancer (18) 18
humans (18) 18
oncology (16) 16
female (13) 13
middle aged (11) 11
chemotherapy (9) 9
male (9) 9
aged (8) 8
animals (8) 8
cell biology (8) 8
clinical trials (8) 8
adult (7) 7
care and treatment (7) 7
review (7) 7
tumors (7) 7
apoptosis (6) 6
cancer therapies (6) 6
expression (6) 6
health aspects (6) 6
lung cancer (6) 6
research (6) 6
treatment outcome (6) 6
aged, 80 and over (5) 5
colorectal cancer (5) 5
hematology, oncology and palliative medicine (5) 5
life sciences (5) 5
medical colleges (5) 5
analysis (4) 4
autophagy (4) 4
breast cancer (4) 4
carcinoma, hepatocellular - drug therapy (4) 4
kinases (4) 4
liver neoplasms - drug therapy (4) 4
multidisciplinary sciences (4) 4
niacinamide - analogs & derivatives (4) 4
therapy (4) 4
angiogenesis (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis - drug effects (3) 3
autolysosome (3) 3
autophagosome (3) 3
carcinoma (3) 3
cell growth (3) 3
cell line, tumor (3) 3
chaperone-mediated autophagy (3) 3
china (3) 3
deoxyribonucleic acid--dna (3) 3
double-blind (3) 3
double-blind method (3) 3
endothelial growth-factor (3) 3
flux (3) 3
genetic aspects (3) 3
genetic predisposition to disease (3) 3
genetics (3) 3
immunotherapy (3) 3
internal medicine (3) 3
kaplan-meier estimate (3) 3
lc3 (3) 3
leukemia (3) 3
liver cancer (3) 3
lysosome (3) 3
macroautophagy (3) 3
management (3) 3
medical prognosis (3) 3
medicine (3) 3
medicine & public health (3) 3
medicine, research & experimental (3) 3
metastasis (3) 3
neoplasm metastasis (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
p53 (3) 3
phagophore (3) 3
phenylurea compounds - adverse effects (3) 3
prognosis (3) 3
proteins (3) 3
rodents (3) 3
stress (3) 3
studies (3) 3
sunitinib (3) 3
vacuole (3) 3
acute myeloid-leukemia (2) 2
alleles (2) 2
antigens (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
article (2) 2
asian continental ancestry group - genetics (2) 2
autophagy - drug effects (2) 2
benzenesulfonates - therapeutic use (2) 2
cancer pain (2) 2
cancer-cells (2) 2
cell cycle (2) 2
cell lung-cancer (2) 2
cell survival (2) 2
cells (2) 2
colorectal carcinoma (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 777 - 786
Summary Background The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | THERAPY | NSCLC | ONCOLOGY | ADENOCARCINOMA | OPEN-LABEL | EGFR | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Administration, Intravenous | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 619 - 629
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 371 - 383
Journal Article
by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Acevedo Arozena, Abraham and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Algül, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexandru and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sandro and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and An, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Andreadi, Catherine K and Andrieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailendra and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexandre and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Awale, Suresh and Azad, Neelam and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ... and Medicinska fakulteten and Region Östergötland and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Institutionen för medicin och hälsa and Avdelningen för läkemedelsforskning and Avdelningen för cellbiologi
Autophagy, ISSN 1554-8627, 01/2016, Volume 12, Issue 1, pp. 1 - 222
Journal Article